We’re pleased to be involved in the following conferences coming up in the first half of 2022. Please do come and say hello!
DIA Latin American Regulatory Conference
14-16th March 2022, Virtual
Tuesday 15th March 12:15-1:30PM (ET), Session 2: Reliance and Good Regulatory Practices
Latin American Systems to Enable Reliance: Best Practices and Recommendations
Dr Mario Alanís Garza, Senior Consultant, CIRS
Tuesday 15th March 2:30-3:50PM (ET), Session 3: Regulatory Convergence and Collaboration
Opportunities for Greater Convergence in Latam
Dr Lawrence Liberti, Adjunct Research Professor, Reg Affairs and Quality Assurance Graduate Program, Temple University School of Pharmacy, and Senior Advisor, CIRS
DIA Europe
29th-31st March 2022, Brussels & Virtual
Global Pharmaceutical Regulatory Affairs Summit
6-13th April 2022, Berlin & Virtual
Dr Mario Alanís Garza, Senior Consultant, CIRS, and Dr Lawrence Liberti, Senior Advisor, CIRS, are involved in the following sessions:
- DIGITAL EXPERIENCE: DAY 4 – Mon, 11 Apr 13:15 – 14:15 (CEST) – Pandemic Readiness – Lessons Learned from COVID-19 in Ensuring Regulatory Agility
- DIGITAL EXPERIENCE: DAY 5 – Tues, 12 Apr 13:50 – 14:50 (CEST) – Updates on Convergence & Reliance Efforts for LATAM
BioHabana 2022 Congress
25-29th April 2022, Cuba & Virtual
Friday 29th April 12.30-12.45PM (ET), Regulatory Session: Working Towards Regulatory Convergence and Reliance
Latin American Experience of Reliance: Challenges and Opportunities
Dr Mario Alanís Garza, Senior Consultant, CIRS
RAPS Euro Convergence
10-12th May 2022, Amsterdam
Dr Magda Bujar, Manager of Strategic Development, CIRS, is involved in the following sessions:
- Wednesday, May 11, 2022 (13:30 – 14:30 CEST) – Conditional Approval Pathways and Strategies
- Thursday, May 12, 2022 (13:30 – 14:30 CEST) – Regulatory Business – Global Regulatory Outlook
DIA Global Annual Meeting
19th-23rd June 2022, Chicago & Virtual
Approaches to regulatory worksharing and collaboration – are they fit-for-purpose and how should they evolve post-pandemic?
How are international standards and regulatory science building trust, increasing competency, and enabling reliance?
Session Chair: Dr Magda Bujar, Manager of Strategic Development, CIRS
Meeting Regulatory Expectations: What Needs to be Considered When Using Digital Technologies to Generate Clinical Evidence?
Session Chair: Dr Jenny Sharpe, Senior Scientific Writer, CIRS
HTAi Annual Meeting
25th-29th June 2022, Utrecht and Virtual
Tina Wang, CIRS Senior Manager of HTA Programme and Strategic Partnerships is involved in the following session:
- Interactions between regulatory, HTA and companies: A multi-stakeholder survey on the current experiences and future landscape evolvement
Dr Belen Sola, CIRS HTA Research Analyst, will also be presenting the following posters:
- Associations Of Orphan Designation And other Drug Development-Related Factors On The Rollout times and Health Technology Assessment Recommendations Of New Active Substances
- Impact Of Parallel Submission On The Rollout Time and Health Technology Assessment Recommendation Of New Active Substances